Form 4: BioMarin Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jeffrey Robert Ajer, EVP and Chief Commercial Officer of BioMarin Pharmaceutical Inc., disposed of 22,580 shares of common stock on March 15, 2024, to cover tax obligations.
Summary
- On March 15, 2024, Jeffrey Robert Ajer, the EVP and Chief Commercial Officer of BioMarin Pharmaceutical Inc., disposed of 22,580 shares of common stock.
- The transaction was executed at a price of $83.87 per share.
- Following the transaction, Ajer directly owns 71,467 shares of BioMarin common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine stock sale for tax purposes and doesn't inherently indicate positive or negative news about the company's performance.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook on the company's future, but it's something investors monitor.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock disposal transaction |
| 03/19/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.